E. Skogh

发表

Interindividual variation in olanzapine concentration influenced by UGT1A4 L48V polymorphism in serum and upstream FMO polymorphisms in cerebrospinal fluid.

M. Dahl, M. G. Scordo, Mao Mao, 2012, Journal of clinical psychopharmacology.

Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluid.

M. Dahl, E. Skogh, M. Josefsson, 2010, Journal of pharmaceutical and biomedical analysis.

Cerebrospinal fluid kynurenic acid in male patients with schizophrenia – correlation with monoamine metabolites

E. Jönsson, S. Erhardt, E. Skogh, 2007, Acta Neuropsychiatrica.

Studies on Variability in Olanzapine Disposition

E. Skogh, 2011 .

High Correlation Between Serum and Cerebrospinal Fluid Olanzapine Concentrations in Patients With Schizophrenia or Schizoaffective Disorder Medicating With Oral Olanzapine as the Only Antipsychotic Drug

M. Dahl, E. Skogh, M. Josefsson, 2011, Journal of clinical psychopharmacology.

Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report.

F. Bengtsson, E. Skogh, C. Nordin, 1999, Therapeutic drug monitoring.

Taurine and glutathione in plasma and cerebrospinal fluid in olanzapine treated patients with schizophrenia

K. Öllinger, M. Samuelsson, Kristina Lundberg, 2013, Psychiatry Research.

Therapeutic Drug Monitoring Data on Olanzapine and Its N-Demethyl Metabolite in the Naturalistic Clinical Setting

M. Reis, F. Bengtsson, M. Dahl, 2002, Therapeutic drug monitoring.

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

K. Blennow, S. Erhardt, L. Lindström, 2001, Neuroscience Letters.

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

M. Holtze, S. Erhardt, K. Linderholm, 2012, Schizophrenia bulletin.

Cerebrospinal fluid levels of sphingolipids associate with disease severity in first episode psychosis patients

I. Agartz, L. Farde, F. Piehl, 2018, Schizophrenia Research.

Imbalanced Kynurenine Pathway in Schizophrenia

I. Schuppe-Koistinen, S. Erhardt, M. Samuelsson, 2014, International journal of tryptophan research : IJTR.

Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.

C. Svensson, I. Schuppe-Koistinen, S. Erhardt, 2015, Journal of psychiatry & neuroscience : JPN.